Barrier Therapeutics Misled Over Clinical Studies, Suit Says
Barrier Therapeutics Inc. misled investors about the success of its clinical-stage biopharmaceuticals, according to a complaint filed by investors in federal court Friday....To view the full article, register now.
Already a subscriber? Click here to view full article